“…Specifically then, given ͑1͒ the problems in maintaining CTDI as a relevant dose index, ͑2͒ the availability of MOSFET ͑or TLD, if preferred͒ dosimeters that are very small, sensitive, and convenient to use, and ͑3͒ the commercial availability of heterogeneous whole-body anthropomorphic phantoms such as the ATOM ® phantoms 21,22 and the Alderson radiation therapy phantoms, 23,24 perhaps it is time to consider retiring ͑with honor͒ the CTDI-inhomogeneousphantoms approach to CT QA/DO. One might envisage CTDI measurements being replaced by direct simultaneous MOSFET or TLD measurements of doses at locations in appropriate organs of a full-body anthropomorphic phantom, perhaps appropriate subsets of stomach, colon, breast, lung, gonads, thyroid, bladder, esophagus, liver, brain, and relevant bone marrow.…”